Sequent Scientific holds 100% shareholding in Belgium-based Fendigo SA; stock soars 2%

The company acquired shares from the veterinary pharmaceutical company at a total price of €551075.

April 01, 2021 12:11 IST India Infoline News Service

Sequent Scientific Limited has consolidated its shareholding in Fendigo SA, Belgium to make Fendigo SA by acquiring a 7.5% stake from Bernard Bradfer in Fendigo SA through Alivira Animal Health Limited, Ireland, a wholly-owned subsidiary of the company.

The company was holding a 92.5% stake in Fendigo SA and consequent to this acquisition, Fendigo SA has become a wholly owned subsidiary of the company. The shares were acquired at a total price of €551075.

Fendigo is a veterinary pharmaceutical company operating in the Benelux region. The company is involved in sales and marketing of veterinary and health products for pets, farm animals, Horses, and poultry.

Sequent Scientific Ltd was trading at Rs245.70 per piece up Rs4.80 or 1.99% at around 12.15 pm on the BSE.

Related Story

Get Access to Stock Reports+ and Customised Investment Ideas